ROUNDTABLE: Optimizing the Number of Potency Assays Performed to Accelerate Commercialization Without Draining Resources

Time: 2:45 pm
day: Day 1

Details:

Roundtable discussions include a larger focus on group discussion. A moderator will introduce the session topic and

attendees then split into groups to discuss a series of predetermined agenda points. At the end, all groups report back on their discussions, and findings are collated.

This roundtable will cover:

  • Meeting regulatory requirements for potency assessment
  • The roadmap to get there: having phase-appropriate potency assays at the ready for critical milestones
  • Being smart about assigning resources while developing a potency matrix

Speakers:

Susan Rutberg
Susan Rutberg